The EHA Research Roadmap: Transfusion Medicine

The European Hematology Association (EHA) published an updated EHA Research Roadmap. The Roadmap presents research and clinical science priorities in hematology, therefore supporting a more informed, focused, and ideally a more funded future for European hematology research. Notably, the updated Roadmap highlights the continued need for evidence for safe and effective use of blood components, including how donor/donation characteristics impact on outcomes after transfusion. Read the full EHA Research Roadmap here.

Stay up to date

    © CSL 2026

    Blood & Beyond is a multi-stakeholder initiative funded by CSL, involving experts from the fields of haematology, transfusion medicine, anaesthesiology, patient blood management, nursing, patient advocacy, health economics, and hospital management, with support from policymakers committed to driving improvements in this area. The aim of the initiative is to raise awareness of the importance of good blood health and of the impact of anaemia on patients, healthcare systems and society at large, with the overarching goal to help advance policies and practices that improve patient outcomes by supporting patient-centricity in anaemia prevention, diagnosis, and management through patient blood management (PBM) and innovation.

    Contact

    For further information and queries, please contact the Blood and Beyond Secretariat: javier.lopezpanos@dgagroup.com

    Privacy Preference Center